Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus reuteri DSM 17938 and Reduced Fecal Calprotectin Levels

Doses used in studies

CFU/day: 500 million (median 500 million, IQR 500 million–500 million) — 1 study

1 of 1 paper

Post hoc analysis of fecal samples from responders and non-responders to Lactobacillus reuteri DSM 17938 intervention.
- 2020-09-01
- RCT · n = 44
- Acta biochimica Polonica 67(3)
- - Henryk Szymanski
  - Piotr Mlynarz
  - Badr Qasem
  - Agnieszka Korzeniowska-Kowal
  - Bogumiła Szponar
  - Małgorzata Kałwak-Baran
  - Hania Szajewska
- PubMed: 32945647
- DOI: 10.18388/abp.2020_5344
3 Insights on
- Reduced Fecal Calprotectin Levels
- High evidence
- Children
its level was significantly lower after intervention in the responder group.
Effect
Beneficial
Effect size
Small
Significant
Yes